NO984284L - Nye tripeptidforbindelser og anti-AIDS-legemidler - Google Patents

Nye tripeptidforbindelser og anti-AIDS-legemidler

Info

Publication number
NO984284L
NO984284L NO984284A NO984284A NO984284L NO 984284 L NO984284 L NO 984284L NO 984284 A NO984284 A NO 984284A NO 984284 A NO984284 A NO 984284A NO 984284 L NO984284 L NO 984284L
Authority
NO
Norway
Prior art keywords
aids drugs
compounds
tripeptide compounds
new tripeptide
new
Prior art date
Application number
NO984284A
Other languages
English (en)
Norwegian (no)
Other versions
NO984284D0 (no
Inventor
Haruo Takaku
Satoshi Nojima
Tsutomu Mimoto
Keisuke Terashima
Yoshiaki Kiso
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO984284D0 publication Critical patent/NO984284D0/no
Publication of NO984284L publication Critical patent/NO984284L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO984284A 1996-12-27 1998-09-16 Nye tripeptidforbindelser og anti-AIDS-legemidler NO984284L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35922696 1996-12-27
JP15052097 1997-05-23
PCT/JP1997/004734 WO1998029118A1 (fr) 1996-12-27 1997-12-22 Nouveaux composes de tripeptides et medicaments anti-sida

Publications (2)

Publication Number Publication Date
NO984284D0 NO984284D0 (no) 1998-09-16
NO984284L true NO984284L (no) 1999-08-26

Family

ID=26480090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984284A NO984284L (no) 1996-12-27 1998-09-16 Nye tripeptidforbindelser og anti-AIDS-legemidler

Country Status (5)

Country Link
US (1) US6291432B1 (fr)
EP (1) EP0900566A4 (fr)
CA (1) CA2249747A1 (fr)
NO (1) NO984284L (fr)
WO (1) WO1998029118A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403818B1 (en) 2000-02-28 2002-06-11 Eisai Co., Ltd. Process for producing α-hydroxy-carbonyl compound
US6593455B2 (en) 2001-08-24 2003-07-15 Tripep Ab Tripeptide amides that block viral infectivity and methods of use thereof
US6455670B1 (en) 2001-09-06 2002-09-24 Tripep Ab Pentamer peptide amide, ALGPG-NH2, that inhibits viral infectivity and methods of use thereof
WO2003024995A1 (fr) 2001-09-19 2003-03-27 Tripep Ab Molecules bloquant l'infectivite virale et methodes d'utilisation associees

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003842A1 (fr) 1987-10-21 1989-05-05 The Upjohn Company Inhibiteurs de renine contenant une fraction de (1-amino-2-hydroxy-2-heterocyclique) ethyle
US4963655A (en) 1988-05-27 1990-10-16 Mayo Foundation For Medical Education And Research Boron analogs of amino acid/peptide protease inhibitors
CA1340588C (fr) * 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides
US5086165A (en) 1989-03-08 1992-02-04 Washington University Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond
US5342922A (en) 1989-03-08 1994-08-30 Washington University Inhibitors of retroviral protease
DE3913272A1 (de) 1989-04-22 1990-10-25 Hoechst Ag Dipeptid-derivate mit enzym-inhibitorischer wirkung
US5212157A (en) 1989-06-06 1993-05-18 Bio-Mega, Inc. Enzyme inhibitors
US5126326A (en) 1989-06-06 1992-06-30 Bio-Mega, Inc. Enzyme inhibiting peptide derivatives
DE4001236A1 (de) 1990-01-18 1991-07-25 Bayer Ag Neue peptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, insbesondere als arzneimittel gegen retroviren
EP0438311A3 (en) 1990-01-19 1992-07-01 Merck & Co. Inc. Di- and tripeptide renin inhibitors
EP0546115A1 (fr) 1990-08-24 1993-06-16 The Upjohn Company Peptides contenant des amino-polyols utilises comme mimes d'etats de transition
US5188950A (en) 1990-10-11 1993-02-23 Merck & Co., Inc. Method of preparing HIV protease inhibitors
US5192668A (en) 1990-10-11 1993-03-09 Merck & Co., Inc. Synthesis of protease inhibitor
US5187074A (en) 1990-10-11 1993-02-16 Merck & Co., Inc. Method of hydroxylation with ATCC 55086
JPH05294993A (ja) 1990-10-22 1993-11-09 Takeda Chem Ind Ltd レトロウイルスプロテアーゼ阻害物質
US5475013A (en) 1990-11-19 1995-12-12 Monsanto Company Retroviral protease inhibitors
EP0559793A1 (fr) 1990-11-30 1993-09-15 Smithkline Beecham Corporation Inhibiteurs de la protease du vih
CA2056911C (fr) 1990-12-11 1998-09-22 Yuuichi Nagano Inhibiteurs de la protease de vih
HUT60282A (en) * 1991-02-08 1992-08-28 Sankyo Co Process for producing new beta-amino-alpha-hydroxycarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
IE922316A1 (en) 1991-07-17 1993-01-27 Smithkline Beecham Corp Retroviral protease inhibitors
JPH05178824A (ja) 1991-08-05 1993-07-20 Takeda Chem Ind Ltd アスパラギン誘導体およびその用途
WO1993008184A1 (fr) 1991-10-23 1993-04-29 Merck & Co., Inc. Inhibiteurs de la protease du vih______________________
WO1993013066A1 (fr) * 1991-12-20 1993-07-08 Syntex (U.S.A.) Inc. Amides cycliques d'acides 3-amino-2-hydroxy-carboxyliques utilises comme inhibiteurs de la protease du vih
US5644028A (en) 1992-05-13 1997-07-01 Japan Energy Corporation Process for producing peptide derivatives and salts therefor
AU662434B2 (en) 1992-08-07 1995-08-31 Sankyo Company Limited Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
JPH06100533A (ja) * 1992-08-07 1994-04-12 Sankyo Co Ltd Ｈｉｖプロテアーゼ阻害活性を有するペプチド誘導体
US5491166A (en) 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
US5554653A (en) 1992-12-22 1996-09-10 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
EP0604182B1 (fr) 1992-12-22 2000-10-11 Eli Lilly And Company Inhibiteurs de la protéase du VIH
US5434265A (en) 1992-12-22 1995-07-18 Eli Lilly And Company Inhibitors of HIV protease
MX9308016A (es) 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
JPH06220031A (ja) * 1993-01-25 1994-08-09 Japan Energy Corp ペプチド誘導体またはその塩の製造法
WO1994018192A1 (fr) 1993-02-12 1994-08-18 Merck & Co., Inc. Derives de piperazine utiles comme inhibiteurs de la protease du vih
AU6828894A (en) 1993-05-14 1994-12-12 Merck & Co., Inc. Hiv protease inhibitors
US5587514A (en) 1993-11-08 1996-12-24 Emory University Diastereoselective synthesis of hydroxyethylene dipeptide isosteres
US5476874A (en) 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
US5492910A (en) 1994-11-17 1996-02-20 Bristol-Myers Squibb Co. Retrocarbamate protease inhibitors
WO1996028423A1 (fr) 1995-03-15 1996-09-19 Sankyo Company, Limited Composes dipeptidiques de structure ahpba
JP3408379B2 (ja) * 1995-06-30 2003-05-19 株式会社ジャパンエナジー 新規なジペプチド化合物又はその薬理的に許容される塩及びその医薬用途

Also Published As

Publication number Publication date
EP0900566A1 (fr) 1999-03-10
EP0900566A4 (fr) 2001-04-25
AU721578B2 (en) 2000-07-06
US6291432B1 (en) 2001-09-18
WO1998029118A1 (fr) 1998-07-09
CA2249747A1 (fr) 1998-07-09
AU7888598A (en) 1998-07-31
NO984284D0 (no) 1998-09-16

Similar Documents

Publication Publication Date Title
FI950309A0 (fi) Proliiniamidijohdannaisia
HUP0401740A2 (hu) N-szubsztituált hidroxipirimidinon-karboxamid HIV-integráz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
DK0719253T3 (da) 3-amino-5-carboxy-substituerede piperidiner og 3-amino-4-carboxy-substituerede pyrrolidiner som tachykininantagonister
NO20024177L (no) Farmasöytiske preparater inneholdende azetidinderivater, de nye azetidinderivater og deres fremstilling
ES2055860T3 (es) Derivados 2-aminopirimidinona.
JO2646B1 (en) New differentiated cyclic compounds as beta - lactam inhibitors
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
NO307047B1 (no) Nye hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere, farmasøytisk preparat inneholdende slike, og anvendelse derav
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
PT1263730E (pt) Derivados amina para o tratamento de apoptose
NO996108L (no) 9-oksinerytromycinderivater
EP1396493A4 (fr) Composes heterocycliques
NO953876D0 (no) HIV-proteaseinhibitorer som er anvendbare for behandling av AIDS
CA2336412A1 (fr) Medicament pour le traitement du diabete
BR0111678A (pt) Composições medicinais contendo derivados de propenona
NO934718L (no) Nye HIV protease inhibitorer
WO2000059285A3 (fr) Nouveaux inhibiteurs de lactame de metalloproteases matricielles, de tnf-alpha, et de l'aggrecanase
AP9901462A0 (en) Stable non-hygroscopic crystalline form of N-[N-N-(4-(Piperidin-4-YL)Butanoyl)-N-Ethylglycyl] amide.
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
DE69823851D1 (de) Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund
WO2002004416A3 (fr) Inhibiteurs de metalloprotease a base de lactame
ATE253359T1 (de) Antithrombotische mittel
NO984284L (no) Nye tripeptidforbindelser og anti-AIDS-legemidler
DE69828522D1 (de) Antithrombotische mittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application